L-type calcium channel blockers and Parkinson disease in Denmark
✍ Scribed by Beate Ritz; Shannon L. Rhodes; Lei Qian; Eva Schernhammer; Jørgen H. Olsen; Søren Friis
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 103 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
and Modification codes. Time-dependent Cox proportional hazards regression models Department of Epidemiology, University of were used to assess associations between incident breast carcinoma and the use of Washington, Seattle, Washington. specific antihypertensive medication including calcium chann
## Objectives: In previous trials, patients with type 2 diabetes using calcium channel blockers (ccb) have suffered a less favourable outcome when compared with patients on other treatments. the present study was designed to compare mortality in type 2 diabetes patients using either ccb or beta blo
## Abstract A new calcium channel blocker, niludipine, was administered intravenously to nine patients with coronary artery disease in order to investigate its effects on left ventricular systolic and diastolic function, coronary sinus blood flow, and myocardial lactate metabolism. Coronary sinus p
Multiple types of voltage-activated calcium (Ca 2؉ ) channels are present in all nerve cells examined so far; however, the underlying functional consequences of their presence is often unclear. We have examined the contribution of Ca 2؉ influx through Nand L-type voltage-activated Ca 2؉ channels in